Aderbasib
- Generic Name
- Aderbasib
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
Phase 1
Terminated
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 68
- Registration Number
- NCT00864175
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 41
- Registration Number
- NCT00820560
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath